From our analysis of 39 neighboring proteins of genetic risk factors in the cytokine signaling pathway, these findings suggest TNFRSF1A, IL1R1, and IL6ST are promising therapeutic targets and biomarkers for developing therapies and diagnostics for RA and related inflammatory diseases. Here, TNFRSF1A is linked to rheumatoid arthritis.